NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

We have included the web address to online sources used in developing and reviewing this article for documentation purposes only. Links included on this Sources page are valid, working links at the time they are posted. Please be aware that the source owner may, from time to time, reorganize the source web site, which can result in broken links on our pages. If you wish to access a source and come across a broken link, you may still be able to access it by entering just the parent web address in your browser's address bar (eg, "www.nih.gov") and then by entering the source title in the site's search feature.

S2
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

S3
Check, W. (1998 July) Reaching agreement on tumor markers [39 paragraphs]. CAP Today, In the News [On-line journal]. Available FTP: http://www.cap.org/captoday/archive/1998/julycover.html

S4
NCI (1998 April 27). Tumor markers [24 paragraphs]. National Cancer Institute, Cancer Facts [On-line information]. Available FTP: http://cis.nci.nih.gov/fact/5_18.htm

S5
ACS (2000 July 19). Tumor Markers [63 paragraphs]. American Cancer Society, Prevention and Early Detection [On-line information]. Available online

S6
AACC (2001 July 27) Use of Tumor Markers in Cancer Patients Leads to Better Detection, Decreasing Mortality [15 paragraphs]. AACC Media Center, American Association for Clinical Chemistry [On-line press release]. Available FTP: http://www.aacc.org/media/TumorMarkers.pdf

S7
ASCO (1996 May 17, adopted, revision every 3 years). CA 15-3 as a Marker for Breast Cancer [15 paragraphs]. American Society for Clinical Oncologists, Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer [On-line guidelines]. Available FTP: http://www.asco.org/prof/pp/html/guide/tumor/m_tumor10.htm

S8
Merck (2000). Cancer and the Immune System [18paragraphs]. The Merck Manual of Medical Information – Home Edition, Section 15 Cancer, Ch 163 [On-line information]. Available FTP: http://www.merck.com/pubs/mmanual_home/sec15/163.htm

S9
Duffy, M. (1999). CA 15-3 and related mucins as circulating markers in breast cancer [36 paragraphs]. Ann Clin Biochem [On-line journal]. Vol 36: 579-586. Available FTP: http://www.leeds.ac.uk/acb/annals/annals_pdf/Sept%2099/ACB579.PDF

S10
Srirangam, S. and Harland, R. (2001). Management of Advanced Breast Cancer [27 paragraphs]. Forum for Registrars In Surgical Training [On-line information]. Available FTP: http://www.frist.org/asit/meetings/yearbook2001/BREAST%20CANCER.pdf